Formulary - Drug-related clinical news & analysis for hospital & managed-care P&T members

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Previous StoryPlay / PauseNext Story
Focus On . . .
Fampridine-SR: A potassium-channel blocker for the improvement of walking ability in patients with MS
Fampridine-SR is a sustained-release oral medication that is pending FDA approval for the symptomatic treatment of multiple sclerosis (MS).
Clinical News
Bloodstream infections and contaminated prefilled syringes: issues of medication safety
An investigation into a multistate outbreak of Serratia marcescens bloodstream infections (BSIs) published in the Archives of Internal Medicine found an association between the BSIs and contamination of prefilled syringes.
Two antimalaria drugs are tolerated regimens in regions with resistance
In a review published in The Cochrane Library, researchers determined that atovaquone-proguanil and doxycycline were well tolerated by most travelers and are less likely than mefloquine to cause adverse neuropsychiatric outcomes.
Thiopurines increase lymphoproliferative disorder risk in IBD patients
Patients with inflammatory bowel disease receiving thiopurines are at increased risk of developing lymphoproliferative disorder, according to a French prospective observational cohort study, which was published online in The Lancet.

ADVERTISEMENT



Stay connected to Formulary
Receive web-exclusive articles, clinical news, and conference updates!
SUGGESTION BOX
Click here to leave a comment in our suggestion box.

Modern Medicine logoFormulary archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting FormularyJournal.com for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

MEDWATCH DRUG SAFETY UPDATES
Cardiac Science Corp. Powerheart and CardioVive Automated External Defibrillators: Initial Communication
Vicks Sinex Nasal Spray - Recall
RockHard Weekend - product contains undeclared drug ingredient
Cardiovascular Systems ViperSheath Sheath Introducer - Recall
IDS Sports Dietary Supplements - Recall

Last updated on Thu Nov 19 20:00:00 EST 2009

FORMULARY SURVEY OF THE MONTH
Which of the following best describes your organization's use of manufacturer-generated formulary dossiers as a component of your P&T drug evaluation processes?
Require a dossier on most new products and utilize extensively in development of P&T materials
Request dossiers periodically and utilize only selective components in development of P&T materials
Use dossiers only as a backup reference tool to support internal P&T monograph development processes
Rarely request dossiers
Do not utilize dossiers at all
Require a dossier on most new products and utilize extensively in development of P&T materials
0%
Request dossiers periodically and utilize only selective components in development of P&T materials
60%
Use dossiers only as a backup reference tool to support internal P&T monograph development processes
0%
Rarely request dossiers
0%
Do not utilize dossiers at all
40%

ADVERTISEMENT

Click here